{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:39:34Z","timestamp":1774539574031,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,16]]},"DOI":"10.7759\/cureus.47108","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T11:36:00Z","timestamp":1697456160000},"source":"Crossref","is-referenced-by-count":10,"title":["Neurological Manifestations of Connective Tissue Disorders"],"prefix":"10.7759","author":[{"given":"Riddhi S","family":"Poshattiwar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sourya","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samarth","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-7020-4086-3.00030-8","article-title":"Connective tissue disorders: systemic lupus erythematosus, Sj\u00f6gren's syndrome, and scleroderma","volume":"119","author":"Streifler JY","year":"2014","unstructured":"Streifler JY, Molad Y. Connective tissue disorders: systemic lupus erythematosus, Sj\u00f6gren's syndrome, and scleroderma. Handb Clin Neurol. 2014, 119:463-73. 10.1016\/B978-0-7020-4086-3.00030-8","journal-title":"Handb Clin Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00541","article-title":"Autoantibodies associated with connective tissue diseases: what meaning for clinicians?","volume":"9","author":"Didier K","year":"2018","unstructured":"Didier K, Bolko L, Giusti D, Toquet S, Robbins A, Antonicelli F, Servettaz A. Autoantibodies associated with connective tissue diseases: what meaning for clinicians?. Front Immunol. 2018, 9:541. 10.3389\/fimmu.2018.00541","journal-title":"Front Immunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/815038","article-title":"A systematic review of serum biomarkers anti-cyclic citrullinated peptide and rheumatoid factor as tests for rheumatoid arthritis","volume":"2011","author":"Taylor P","year":"2011","unstructured":"Taylor P, Gartemann J, Hsieh J, Creeden J. A systematic review of serum biomarkers anti-cyclic citrullinated peptide and rheumatoid factor as tests for rheumatoid arthritis. Autoimmune Dis. 2011, 2011:815038. 10.4061\/2011\/815038","journal-title":"Autoimmune Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/ar3495","article-title":"Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features","volume":"13","author":"Mierau R","year":"2011","unstructured":"Mierau R, Moinzadeh P, Riemekasten G, et al.. Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features. Arthritis Res Ther. 2011, 13:R172. 10.1186\/ar3495","journal-title":"Arthritis Res Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/art.39214","article-title":"Prediction of Sj\u00f6gren\u2019s syndrome years before diagnosis and identification of patients with early onset and severe disease course by autoantibody profiling","volume":"67","author":"Theander E","year":"2015","unstructured":"Theander E, Jonsson R, Sj\u00f6str\u00f6m B, Brokstad K, Olsson P, Henriksson G. Prediction of Sj\u00f6gren\u2019s syndrome years before diagnosis and identification of patients with early onset and severe disease course by autoantibody profiling. Arthritis Rheumatol. 2015, 67:2427-36. 10.1002\/art.39214","journal-title":"Arthritis Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13491","article-title":"Presence of anti-phosphatidylserine-prothrombin complex antibodies and anti-moesin antibodies in patients with polyarteritis nodosa","volume":"44","author":"Okano T","year":"2017","unstructured":"Okano T, Takeuchi S, Soma Y, et al.. Presence of anti-phosphatidylserine-prothrombin complex antibodies and anti-moesin antibodies in patients with polyarteritis nodosa. J Dermatol. 2017, 44:18-22. 10.1111\/1346-8138.13491","journal-title":"J Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2020.06.005","article-title":"Granulomatosis with polyangiitis (Wegener's)","volume":"87","author":"Pu\u00e9chal X","year":"2020","unstructured":"Pu\u00e9chal X. Granulomatosis with polyangiitis (Wegener's). Joint Bone Spine. 2020, 87:572-8. 10.1016\/j.jbspin.2020.06.005","journal-title":"Joint Bone Spine"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel282","article-title":"Epidemiology of connective tissue disorders","volume":"45 Suppl 3","author":"Gaubitz M","year":"2006","unstructured":"Gaubitz M. Epidemiology of connective tissue disorders. Rheumatology (Oxford). 2006, 45 Suppl 3:iii3-4. 10.1093\/rheumatology\/kel282","journal-title":"Rheumatology (Oxford)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/art.21955","article-title":"Mortality in systemic lupus erythematosus","volume":"54","author":"Bernatsky S","year":"2006","unstructured":"Bernatsky S, Boivin JF, Joseph L, et al.. Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006, 54:2550-7. 10.1002\/art.21955","journal-title":"Arthritis Rheum"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2021.02.021","article-title":"Seizures in systemic lupus erythematosus: a scoping review","volume":"86","author":"Rodriguez-Hernandez A","year":"2021","unstructured":"Rodriguez-Hernandez A, Ortiz-Orendain J, Alvarez-Palazuelos LE, Gonzalez-Lopez L, Gamez-Nava JI, Zavala-Cerna MG. Seizures in systemic lupus erythematosus: a scoping review. Seizure. 2021, 86:161-7. 10.1016\/j.seizure.2021.02.021","journal-title":"Seizure"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00138","article-title":"Definition of NPSLE: does the ACR nomenclature still hold?","volume":"5","author":"Vivaldo JF","year":"2018","unstructured":"Vivaldo JF, de Amorim JC, Julio PR, de Oliveira RJ, Appenzeller S. Definition of NPSLE: does the ACR nomenclature still hold?. Front Med (Lausanne). 2018, 5:138. 10.3389\/fmed.2018.00138","journal-title":"Front Med (Lausanne)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-018-0156-8","article-title":"Neuropsychiatric lupus: new mechanistic insights and future treatment directions","volume":"15","author":"Schwartz N","year":"2019","unstructured":"Schwartz N, Stock AD, Putterman C. Neuropsychiatric lupus: new mechanistic insights and future treatment directions. Nat Rev Rheumatol. 2019, 15:137-52. 10.1038\/s41584-018-0156-8","journal-title":"Nat Rev Rheumatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab160","article-title":"Psychosis in systemic lupus erythematosus (SLE): 40-year experience of a specialist centre","volume":"60","author":"Abrol E","year":"2021","unstructured":"Abrol E, Coutinho E, Chou M, et al.. Psychosis in systemic lupus erythematosus (SLE): 40-year experience of a specialist centre. Rheumatology (Oxford). 2021, 60:5620-9. 10.1093\/rheumatology\/keab160","journal-title":"Rheumatology (Oxford)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-019-1012-1","article-title":"Neurological complications in patients with systemic lupus erythematosus","volume":"19","author":"Shaban A","year":"2019","unstructured":"Shaban A, Leira EC. Neurological complications in patients with systemic lupus erythematosus. Curr Neurol Neurosci Rep. 2019, 19:97. 10.1007\/s11910-019-1012-1","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/43pqih","article-title":"Epilepsy in systemic lupus erythematosus","volume":"39","author":"Grasso EA","year":"2021","unstructured":"Grasso EA, Cacciatore M, Gentile C, Breda L, Giacomelli R, Verrotti A. Epilepsy in systemic lupus erythematosus. Clin Exp Rheumatol. 2021, 39:651-9. 10.55563\/clinexprheumatol\/43pqih","journal-title":"Clin Exp Rheumatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-013-1023-z","article-title":"Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome","volume":"120","author":"Baizabal-Carvallo JF","year":"2013","unstructured":"Baizabal-Carvallo JF, Bonnet C, Jankovic J. Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome. J Neural Transm (Vienna). 2013, 120:1579-89. 10.1007\/s00702-013-1023-z","journal-title":"J Neural Transm (Vienna)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S1353-8020(13)70006-3","article-title":"Movement disorders in childhood","volume":"20","author":"Cardoso F","year":"2014","unstructured":"Cardoso F. Movement disorders in childhood. Parkinsonism Relat Disord. 2014, 20:13-16. 10.1016\/S1353-8020(13)70006-3","journal-title":"Parkinsonism Relat Disord"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s100670050069","article-title":"Optic neuropathy in systemic lupus erythematosus and antiphospholipid syndrome (APS): clinical features, pathogenesis, review of the literature and proposed ophthalmological criteria for APS diagnosis","volume":"18","author":"Giorgi D","year":"1999","unstructured":"Giorgi D, Balacco Gabrieli C. Optic neuropathy in systemic lupus erythematosus and antiphospholipid syndrome (APS): clinical features, pathogenesis, review of the literature and proposed ophthalmological criteria for APS diagnosis. Clin Rheumatol. 1999, 18:124-31. 10.1007\/s100670050069","journal-title":"Clin Rheumatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.07.015","article-title":"Neuropsychiatric manifestations in rheumatoid arthritis","volume":"14","author":"Joaquim AF","year":"2015","unstructured":"Joaquim AF, Appenzeller S. Neuropsychiatric manifestations in rheumatoid arthritis. Autoimmun Rev. 2015, 14:1116-22. 10.1016\/j.autrev.2015.07.015","journal-title":"Autoimmun Rev"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11051262","article-title":"Pathogenesis of extraarticular manifestations in rheumatoid arthritis-a comprehensive review","volume":"11","author":"Mitrovi\u0107 J","year":"2023","unstructured":"Mitrovi\u0107 J, Hrka\u010d S, Te\u010der J, Golob M, Ljilja Posavec A, Kolar Mitrovi\u0107 H, Grgurevi\u0107 L. Pathogenesis of extraarticular manifestations in rheumatoid arthritis-a comprehensive review. Biomedicines. 2023, 11:1262. 10.3390\/biomedicines11051262","journal-title":"Biomedicines"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2017.06.005","article-title":"Neurologic manifestations of rheumatoid arthritis","volume":"43","author":"DeQuattro K","year":"2017","unstructured":"DeQuattro K, Imboden JB. Neurologic manifestations of rheumatoid arthritis. Rheum Dis Clin North Am. 2017, 43:561-71. 10.1016\/j.rdc.2017.06.005","journal-title":"Rheum Dis Clin North Am"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-011-1841-z","article-title":"Beyond the joints: neurological involvement in rheumatoid arthritis","volume":"31","author":"Ramos-Remus C","year":"2012","unstructured":"Ramos-Remus C, Duran-Barragan S, Castillo-Ortiz JD. Beyond the joints: neurological involvement in rheumatoid arthritis. Clin Rheumatol. 2012, 31:1-12. 10.1007\/s10067-011-1841-z","journal-title":"Clin Rheumatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/kjm2.12505","article-title":"Pathophysiology of systemic sclerosis (scleroderma)","volume":"38","author":"Rosendahl AH","year":"2022","unstructured":"Rosendahl AH, Sch\u00f6nborn K, Krieg T. Pathophysiology of systemic sclerosis (scleroderma). Kaohsiung J Med Sci. 2022, 38:187-95. 10.1002\/kjm2.12505","journal-title":"Kaohsiung J Med Sci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-011110-130312","article-title":"The pathogenesis of systemic sclerosis","volume":"6","author":"Katsumoto TR","year":"2011","unstructured":"Katsumoto TR, Whitfield ML, Connolly MK. The pathogenesis of systemic sclerosis. Annu Rev Pathol. 2011, 6:509-37. 10.1146\/annurev-pathol-011110-130312","journal-title":"Annu Rev Pathol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.1997.tb00216.x","article-title":"Neurologic abnormalities in two patients with facial hemiatrophy and sclerosis coexisting with morphea","volume":"14","author":"Menni S","year":"1997","unstructured":"Menni S, Marzano AV, Passoni E. Neurologic abnormalities in two patients with facial hemiatrophy and sclerosis coexisting with morphea. Pediatr Dermatol. 1997, 14:113-6. 10.1111\/j.1525-1470.1997.tb00216.x","journal-title":"Pediatr Dermatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000334474.88923.e3","article-title":"Neurologic manifestations of localized scleroderma: a case report and literature review","volume":"71","author":"Kister I","year":"2008","unstructured":"Kister I, Inglese M, Laxer RM, Herbert J. Neurologic manifestations of localized scleroderma: a case report and literature review. Neurology. 2008, 71:1538-45. 10.1212\/01.wnl.0000334474.88923.e3","journal-title":"Neurology"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/719685","article-title":"Neurologic involvement in scleroderma en coup de sabre","volume":"2012","author":"Amaral TN","year":"2012","unstructured":"Amaral TN, Marques Neto JF, Lapa AT, Peres FA, Guirau CR, Appenzeller S. Neurologic involvement in scleroderma en coup de sabre. Autoimmune Dis. 2012, 2012:719685. 10.1155\/2012\/719685","journal-title":"Autoimmune Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-0470","article-title":"Linear scleroderma en coup de sabre with associated neurologic abnormalities","volume":"117","author":"Holland KE","year":"2006","unstructured":"Holland KE, Steffes B, Nocton JJ, Schwabe MJ, Jacobson RD, Drolet BA. Linear scleroderma en coup de sabre with associated neurologic abnormalities. Pediatrics. 2006, 117:e132-6. 10.1542\/peds.2005-0470","journal-title":"Pediatrics"},{"key":"ref29","article-title":"Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases","volume":"13","author":"Marzano AV","year":"2003","unstructured":"Marzano AV, Menni S, Parodi A, Borghi A, Fuligni A, Fabbri P, Caputo R. Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases. Eur J Dermatol. 2003, 13:171-6.","journal-title":"Eur J Dermatol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.74.5.661","article-title":"Linear scleroderma \"en coup de sabre\" coexisting with plaque-morphea: neuroradiological manifestation and response to corticosteroids","volume":"74","author":"Unterberger I","year":"2003","unstructured":"Unterberger I, Trinka E, Engelhardt K, et al.. Linear scleroderma \"en coup de sabre\" coexisting with plaque-morphea: neuroradiological manifestation and response to corticosteroids. J Neurol Neurosurg Psychiatry. 2003, 74:661-4. 10.1136\/jnnp.74.5.661","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1136\/ard.50.4.260","article-title":"Scleroderma 'en coup de sabre'","volume":"50","author":"David J","year":"1991","unstructured":"David J, Wilson J, Woo P. Scleroderma 'en coup de sabre'. Ann Rheum Dis. 1991, 50:260-2. 10.1136\/ard.50.4.260","journal-title":"Ann Rheum Dis"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.5114\/reum.2018.75521","article-title":"Neurological manifestations of primary Sj\u00f6gren's syndrome","volume":"56","author":"Perzy\u0144ska-Mazan J","year":"2018","unstructured":"Perzy\u0144ska-Mazan J, Ma\u015bli\u0144ska M, Gasik R. Neurological manifestations of primary Sj\u00f6gren's syndrome. Reumatologia. 2018, 56:99-105. 10.5114\/reum.2018.75521","journal-title":"Reumatologia"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2012.06.002","article-title":"Central and peripheral neurological complications of primary Sj\u00f6gren's syndrome","volume":"41","author":"Fauchais AL","year":"2012","unstructured":"Fauchais AL, Magy L, Vidal E. Central and peripheral neurological complications of primary Sj\u00f6gren's syndrome. Presse Med. 2012, 41:e485-93. 10.1016\/j.lpm.2012.06.002","journal-title":"Presse Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410270313","article-title":"Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sj\u00f6gren's syndrome","volume":"27","author":"Griffin JW","year":"1990","unstructured":"Griffin JW, Cornblath DR, Alexander E, Campbell J, Low PA, Bird S, Feldman EL. Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sj\u00f6gren's syndrome. Ann Neurol. 1990, 27:304-15. 10.1002\/ana.410270313","journal-title":"Ann Neurol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.2174\/138161208799316366","article-title":"Treatment of central nervous system involvement associated with primary Sj\u00f6gren's syndrome","volume":"14","author":"Ozgocmen S","year":"2008","unstructured":"Ozgocmen S, Gur A. Treatment of central nervous system involvement associated with primary Sj\u00f6gren's syndrome. Curr Pharm Des. 2008, 14:1270-3. 10.2174\/138161208799316366","journal-title":"Curr Pharm Des"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2019.07.005","article-title":"Aseptic meningitis","volume":"175","author":"Tattevin P","year":"2019","unstructured":"Tattevin P, Tchamgou\u00e9 S, Belem A, B\u00e9n\u00e9zit F, Pronier C, Revest M. Aseptic meningitis. Rev Neurol (Paris). 2019, 175:475-80. 10.1016\/j.neurol.2019.07.005","journal-title":"Rev Neurol (Paris)"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000141099.53742.16","article-title":"Neurologic manifestations in primary Sj\u00f6gren syndrome: a study of 82 patients","volume":"83","author":"Delalande S","year":"2004","unstructured":"Delalande S, de Seze J, Fauchais AL, et al.. Neurologic manifestations in primary Sj\u00f6gren syndrome: a study of 82 patients. Medicine (Baltimore). 2004, 83:280-91. 10.1097\/01.md.0000141099.53742.16","journal-title":"Medicine (Baltimore)"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/29.1.21","article-title":"The spectrum of neurological involvement in Sj\u00f6gren's syndrome","volume":"29","author":"Andonopoulos AP","year":"1990","unstructured":"Andonopoulos AP, Lagos G, Drosos AA, Moutsopoulos HM. The spectrum of neurological involvement in Sj\u00f6gren's syndrome. Br J Rheumatol. 1990, 29:21-3. 10.1093\/rheumatology\/29.1.21","journal-title":"Br J Rheumatol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.63.11.1612","article-title":"Peripheral neuropathy in primary sjogren syndrome: a population-based study","volume":"63","author":"G\u00f8ransson LG","year":"2006","unstructured":"G\u00f8ransson LG, Herigstad A, Tjensvoll AB, Harboe E, Mellgren SI, Omdal R. Peripheral neuropathy in primary sjogren syndrome: a population-based study. Arch Neurol. 2006, 63:1612-5. 10.1001\/archneur.63.11.1612","journal-title":"Arch Neurol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.41.142","article-title":"Motor dominant neuropathy in Sj\u00f6gren's syndrome: report of two cases","volume":"41","author":"Mochizuki H","year":"2002","unstructured":"Mochizuki H, Kamakura K, Masaki T, Hirata A, Nakamura R, Motoyoshi K. Motor dominant neuropathy in Sj\u00f6gren's syndrome: report of two cases. Intern Med. 2002, 41:142-6. 10.2169\/internalmedicine.41.142","journal-title":"Intern Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: evidence-based recommendations","volume":"132","author":"Dworkin RH","year":"2007","unstructured":"Dworkin RH, O'Connor AB, Backonja M, et al.. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007, 132:237-51. 10.1016\/j.pain.2007.08.033","journal-title":"Pain"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.48.4.855","article-title":"Peripheral neuropathy associated with sicca complex","volume":"48","author":"Grant IA","year":"1997","unstructured":"Grant IA, Hunder GG, Homburger HA, Dyck PJ. Peripheral neuropathy associated with sicca complex. Neurology. 1997, 48:855-62. 10.1212\/wnl.48.4.855","journal-title":"Neurology"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003632","article-title":"Sj\u00f6gren sensory neuronopathy (Sj\u00f6gren ganglionopathy): Long-term outcome and treatment response in a series of 13 cases","volume":"95","author":"Pereira PR","year":"2016","unstructured":"Pereira PR, Viala K, Maisonobe T, et al.. Sj\u00f6gren sensory neuronopathy (Sj\u00f6gren ganglionopathy): Long-term outcome and treatment response in a series of 13 cases. Medicine (Baltimore). 2016, 95:e3632. 10.1097\/MD.0000000000003632","journal-title":"Medicine (Baltimore)"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2005.12.029","article-title":"Acute sensory neuronopathy as the presenting symptom of Sj\u00f6gren's syndrome","volume":"13","author":"Souayah N","year":"2006","unstructured":"Souayah N, Chong PS, Cros D. Acute sensory neuronopathy as the presenting symptom of Sj\u00f6gren's syndrome. J Clin Neurosci. 2006, 13:862-5. 10.1016\/j.jocn.2005.12.029","journal-title":"J Clin Neurosci"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/s0248-8663(00)80030-2","article-title":"Gorgerot-Sjogren's syndrome simulating amyotrophic lateral sclerosis","volume":"21","author":"Attout H","year":"2000","unstructured":"Attout H, Rahmeh F, Ziegler F. Gorgerot-Sjogren's syndrome simulating amyotrophic lateral sclerosis. Rev Med Interne. 2000, 21:708-10. 10.1016\/s0248-8663(00)80030-2","journal-title":"Rev Med Interne"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.52.0899","article-title":"Hypokalemic paralysis as a presenting manifestation of primary Sj\u00f6gren's syndrome accompanied by vitamin D deficiency","volume":"52","author":"Liao CY","year":"2013","unstructured":"Liao CY, Wang CC, Chen IH, Shiang JC, Liu MY, Tsai MK. Hypokalemic paralysis as a presenting manifestation of primary Sj\u00f6gren's syndrome accompanied by vitamin D deficiency. Intern Med. 2013, 52:2351-3. 10.2169\/internalmedicine.52.0899","journal-title":"Intern Med"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1002\/art.21347","article-title":"Antimuscarinic antibodies in Sj\u00f6gren's syndrome: where are we, and where are we going?","volume":"52","author":"Dawson L","year":"2005","unstructured":"Dawson L, Tobin A, Smith P, Gordon T. Antimuscarinic antibodies in Sj\u00f6gren's syndrome: where are we, and where are we going?. Arthritis Rheum. 2005, 52:2984-95. 10.1002\/art.21347","journal-title":"Arthritis Rheum"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.12.004","article-title":"Churg-Strauss syndrome","volume":"14","author":"Greco A","year":"2015","unstructured":"Greco A, Rizzo MI, De Virgilio A, et al.. Churg-Strauss syndrome. Autoimmun Rev. 2015, 14:341-8. 10.1016\/j.autrev.2014.12.004","journal-title":"Autoimmun Rev"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e3280119854","article-title":"Churg-Strauss syndrome","volume":"19","author":"Pagnoux C","year":"2007","unstructured":"Pagnoux C, Guilpain P, Guillevin L. Churg-Strauss syndrome. Curr Opin Rheumatol. 2007, 19:25-32. 10.1097\/BOR.0b013e3280119854","journal-title":"Curr Opin Rheumatol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.4065\/70.4.337","article-title":"Neurologic manifestations of Churg-Strauss syndrome","volume":"70","author":"Sehgal M","year":"1995","unstructured":"Sehgal M, Swanson JW, DeRemee RA, Colby TV. Neurologic manifestations of Churg-Strauss syndrome. Mayo Clin Proc. 1995, 70:337-41. 10.4065\/70.4.337","journal-title":"Mayo Clin Proc"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2018.04.003","article-title":"Dermatomyositis: current concepts","volume":"36","author":"Bogdanov I","year":"2018","unstructured":"Bogdanov I, Kazandjieva J, Darlenski R, Tsankov N. Dermatomyositis: current concepts. Clin Dermatol. 2018, 36:450-8. 10.1016\/j.clindermatol.2018.04.003","journal-title":"Clin Dermatol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.12968\/hmed.2012.73.sup2.c18","article-title":"Dermatomyositis","volume":"73","author":"Mahil S","year":"2012","unstructured":"Mahil S, Marks D, McCormack M, Rahman A. Dermatomyositis. Br J Hosp Med (Lond). 2012, 73:C18-22. 10.12968\/hmed.2012.73.sup2.c18","journal-title":"Br J Hosp Med (Lond)"},{"key":"ref53","article-title":"Nerve conduction studies in patients with dermatomyositis or polymyositis","volume":"123","author":"Wang Y","year":"2010","unstructured":"Wang Y, Cui L, Chen L, Liu M, Qi X, Li B, Du H. Nerve conduction studies in patients with dermatomyositis or polymyositis. Chin Med J (Engl). 2010, 123:523-6.","journal-title":"Chin Med J (Engl)"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2019.01.007","article-title":"Polyarteritis nodosa neurologic manifestations","volume":"37","author":"de Boysson H","year":"2019","unstructured":"de Boysson H, Guillevin L. Polyarteritis nodosa neurologic manifestations. Neurol Clin. 2019, 37:345-57. 10.1016\/j.ncl.2019.01.007","journal-title":"Neurol Clin"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000200166.90373.41","article-title":"Central nervous system involvement in Wegener granulomatosis","volume":"85","author":"Seror R","year":"2006","unstructured":"Seror R, Mahr A, Ramanoelina J, Pagnoux C, Cohen P, Guillevin L. Central nervous system involvement in Wegener granulomatosis. Medicine (Baltimore). 2006, 85:53-65. 10.1097\/01.md.0000200166.90373.41","journal-title":"Medicine (Baltimore)"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/s0272-6386(01)90002-2","article-title":"Diabetes insipidus and anterior pituitary insufficiency as presenting features of Wegener\u2019s granulomatosis","volume":"37","author":"Garovic VD","year":"2001","unstructured":"Garovic VD, Clarke BL, Chilson TS, Specks U. Diabetes insipidus and anterior pituitary insufficiency as presenting features of Wegener\u2019s granulomatosis. Am J Kidney Dis. 2001, 37:1-3. 10.1016\/s0272-6386(01)90002-2","journal-title":"Am J Kidney Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/185990-neurological-manifestations-of-connective-tissue-disorders","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:05:44Z","timestamp":1707509144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/185990-neurological-manifestations-of-connective-tissue-disorders"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,16]]},"references-count":56,"URL":"https:\/\/doi.org\/10.7759\/cureus.47108","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,16]]}}}